Takeda’s TAK-881-3001 pivotal Phase II/III clinical trial of TAK-881 in patients with PID has met its primary endpoint.The post Takeda’s...
Latus Bio has closed a $97m Series A financing round to expand the reach of its gene therapies targeting wider...
TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic...
Celcuity has reported topline outcomes from the PIK3CA mutant cohort of the Phase III VIKTORIA-1 clinical trial assessing gedatolisib combined...
Novo Nordisk is set to launch Ozempic, its oral GLP-1 receptor agonist pill for adults with type 2 diabetes, in...
MintNeuro has signed a partnership with Motif Neurotech to advance the development of miniature BCI therapy for mental health conditions.The...
Merck KGaA has dosed the first patient in its Phase III clinical programme, evaluating enpatoran in individuals with lupus who...
LEO Pharma has signed a definitive agreement for the acquisition of Replay, which focuses on treating rare genetic dermatological conditions.The...
Ray Therapeutics has received PRIME designation from the EMA for its RTx-015 gene therapy to treat retinitis pigmentosa (RP).The post...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.